Establishment Labs Holdings (ESTA) Cash from Investing Activities (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Cash from Investing Activities of -$2.0 million for Q1 2026, down 46.71% year-over-year from -$3.7 million in Q1 2025, and down 18.0% quarter-over-quarter from -$1.7 million in Q4 2025.
Establishment Labs Holdings (ESTA) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 46.71% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$7.7 million (up 25.86% YoY), while the FY2025 annual figure was -$7.0 million, up 54.98% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$2.0 million, down from -$1.7 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$1.3 million in Q1 2025, with the low at -$13.8 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is -$4.4 million (2024), against an average of -$4.9 million.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 1380.6% in 2022, then jumped 79.84% in 2025.
- Establishment Labs Holdings' Cash from Investing Activities stood at -$10.4 million in 2022, then soared by 55.7% to -$4.6 million in 2023, then jumped by 60.63% to -$1.8 million in 2024, then increased by 8.69% to -$1.7 million in 2025, then decreased by 18.0% to -$2.0 million in 2026.
- Business Quant data shows ESTA's Cash from Investing Activities at -$2.0 million in Q1 2026, -$1.7 million in Q4 2025, and -$2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | -3.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.65 Mn |
| Jun 30, 2026 | -3.65 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | -1.66 Mn |
| Dec 31, 2025 | -1.66 Mn |
| Sep 30, 2025 | -1.96 Mn |
| Sep 30, 2025 | -1.96 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Mar 31, 2025 | -1.34 Mn |
| Mar 31, 2025 | -1.34 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Mar 31, 2024 | -6.63 Mn |
| Mar 31, 2024 | -6.63 Mn |